Literature DB >> 16387005

Histopathologic findings after radial optic neurotomy in central retinal vein occlusion.

Antje Vogel1, Frank G Holz, Karin U Loeffler.   

Abstract

PURPOSE: Radial optic neurotomy (RON) in central retinal vein occlusion (CRVO) is a novel strategy that is aimed at relief of mechanical pressure on the central retinal vein. We report on histopathologic findings in a human eye 18 weeks after RON.
DESIGN: Interventional case report.
METHODS: Eighteen weeks after RON for ischemic CRVO, an eye was enucleated because of neovascular glaucoma and examined histologically.
RESULTS: Histopathologic evidence demonstrated displaced fragments of Bruch's membrane surrounded by retinal tissue at the nasal side of the papilla. A discrete scar was noted at this site that reached the cribriform plate without involving the adjacent sclera or the retinal vessels. The optic nerve showed advanced atrophy with a small temporal sector of viable nerve fibers.
CONCLUSIONS: Histopathologic findings after RON do not provide evidence for the postulated mechanism of action. It appears prudent to further evaluate this technique before its general implementation in the management of CRVO.

Entities:  

Mesh:

Year:  2006        PMID: 16387005     DOI: 10.1016/j.ajo.2005.07.061

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Changes of electroretinogram without improvement of retinal circulation after radial optic neurotomy for central retinal vein occlusion. ERG changes after RON for CRVO.

Authors:  Eiju Sato; Shuichi Yamamoto; Kazuha Ogata; Mariko Kubota; Takeshi Sugawara; Satoshi Mizunoya
Journal:  Doc Ophthalmol       Date:  2008-01-01       Impact factor: 2.379

Review 2.  [Surgical treatments for retinal vein occlusion].

Authors:  N Feltgen; H Agostini; L Hansen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

3.  Radial optic neurotomy for central retinal vein occlusion.

Authors:  Ali-Reza Ramezani
Journal:  J Ophthalmic Vis Res       Date:  2009-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.